Stock listing
MEM Stock Price, News, Filings & Events — Memphasys Ltd
Selected listing: MEM · ASX · AUD · AU
This page tracks Memphasys Ltd's MEM:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MEM:ASX. MEM:ASX is the stock-level entry point for investors researching Memphasys Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Memphasys Ltd (Ticker: MEM) is a public company based in Australia, with a market capitalization of approximately AUD 14.95 million. The company focuses on developing innovative technologies in the field of reproductive health. Memphasys aims to enhance the efficiency of assisted reproductive technologies through its proprietary solutions.

- Ticker
- MEM:ASX
- Asset type
- Stock
- Market cap
- $14.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
Memphasys Ltd MEM:ASX stock context
This page tracks Memphasys Ltd's MEM:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MEM:ASX. MEM:ASX is the stock-level entry point for investors researching Memphasys Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Memphasys Ltd (Ticker: MEM) is a public company based in Australia, with a market capitalization of approximately AUD 14.95 million. The company focuses on developing innovative technologies in the field of reproductive health. Memphasys aims to enhance the efficiency of assisted reproductive technologies through its proprietary solutions.
Latest news from Memphasys Ltd
Felix Registration Achieved in Vietnam and Cartridge Order
August 19, 2026
European Commercial Roll-out continues with Poland Agreement
August 4, 2026
Exclusive Thailand Commercialisation Agreement Secured
June 30, 2026
UK Market Entry & Acceleration of Commercial Expansion
June 24, 2026
Successful $1.2M Placement and Convertible Note Extended
June 17, 2026
Research Memphasys Ltd
Memphasys Ltd investor report
Review AI stock analysis and investor report context for MEM:ASX.
Memphasys Ltd company profile
View the public company page for Memphasys Ltd on 6ix.
Memphasys Ltd news
Read company news and market updates connected to Memphasys Ltd.
Memphasys Ltd investor events
Find investor webinars, events, and replay context for Memphasys Ltd.
Alternate listings
MPHSF:OTC
US · USD
Alternate listing for Memphasys Ltd; the primary context on this page is MEM:ASX.
A2ANGR:LSX
DE · EUR
Alternate listing for Memphasys Ltd; the primary context on this page is MEM:ASX.
IG7:GETTEX
DE · EUR
Alternate listing for Memphasys Ltd; the primary context on this page is MEM:ASX.
IG7:FWB
DE · EUR
Alternate listing for Memphasys Ltd; the primary context on this page is MEM:ASX.
A2ANGR:LS
DE · EUR
Alternate listing for Memphasys Ltd; the primary context on this page is MEM:ASX.
IG7:MUN
DE · EUR
Alternate listing for Memphasys Ltd; the primary context on this page is MEM:ASX.
IG7:SWB
DE · EUR
Alternate listing for Memphasys Ltd; the primary context on this page is MEM:ASX.